Scholarly Index
Agnes Jager
Erasmus MC Cancer Institute; 15,796 total citations; 365 total publications; best world rank #49
Erasmus MC Cancer Institute
15,796Total citations
365Total publications
61H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 726 | NL 34 | 97.90 |
| Advanced Breast Cancer Therapies | Lifetime | 323 | NL 6 | 97.37 |
| BRCA gene mutations in cancer | Lifetime | 499 | NL 21 | 96.71 |
| PARP inhibition in cancer therapy | Lifetime | 544 | NL 14 | 94.17 |
| Breast Cancer Treatment Studies | 2021-2025 | 109 | NL 3 | 98.55 |
| Estrogen and related hormone effects | 2021-2025 | 49 | NL 1 | 95.56 |
| BRCA gene mutations in cancer | 2021-2025 | 145 | NL 4 | 94.85 |
| HER2/EGFR in Cancer Research | 2021-2025 | 218 | NL 3 | 96.58 |
| Advanced Breast Cancer Therapies | 2021-2025 | 214 | NL 4 | 96.27 |
| Cancer Treatment and Pharmacology | 2021-2025 | 330 | NL 7 | 93.37 |
| Cancer Cells and Metastasis | 2021-2025 | 679 | NL 31 | 86.70 |
| PARP inhibition in cancer therapy | 2021-2025 | 788 | NL 13 | 80.86 |
| Cancer-related cognitive impairment studies | 2021-2025 | 582 | NL 48 | 73.53 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 865 | NL 33 | 59.61 |